Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO) — Form 8-K: Current report
AI-generated summary
Thermo Fisher Scientific Inc. reported its financial results for the third quarter ended September 26, 2026. Revenue grew 9% to $12.14 billion, with organic revenue growth of 6%. GAAP diluted EPS increased 9% to $4.64, and adjusted EPS rose 15% to $6.68.
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More TMO filings
- 4
Filed Oct 30, 2026
- 4
Filed Oct 30, 2026
- 8-K
Filed Oct 30, 2026
- 10-Q
Filed Oct 30, 2026
- 144
Filed Oct 28, 2026
- 4
Filed Sep 29, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.